Come check out the @snijderlab over on twitter – it’s never too late 🙂
Author: snijderlab.org
Fortune on Allcyte
How cool, Fortune Magazine has written a piece on our spinoff company Allcyte. Allcyte uses and develops the Pharmacoscopy platform to bring tailored treatments to each cancer patient.
Pharmacoscopy trial presented at ASH2020
The final analysis of the succesful EXALT-1 interventional trial will be presented at the 62nd annual meeting of the American Society for Hematology by Prof. Dr. Philipp Staber from the Medical University of Vienna!
In the EXALT-1 trial, Pharmacoscopy has been used to guide the treatment of patients with advanced aggressive hematological cancers. A preview of the final analysis is available online here: Treatments guided by Pharmacoscopy led to improved progression free survival for 30 out of 56 patients!
SIB Photoshoot
Commissioned by the Swiss Institute of Bioinformatics (sib.swiss), the awesome Nicolas Righetti from Lundi13 took some industrially-themed photos of Berend for the SIB Snijder Lab website. Thanks Nicolas & SIB!
Pharmacoscopy @ EHA25
We’re excited to see our Pharmacoscopy technology so well represented at the biggest annual European hematology meeting!
Giulio Superti-Furga, research director of the Research Center for Molecular Medicine, introduced the European Hematology Association to Pharmacoscopy in a plenary session of the 25th annual EHA meeting. Additionally, Berend presented how deep neural networks can bring pharmacoscopy to the next level for personalized systems medicine, in a session by the Scientific Working Group for Precision Hematology.
SNF Professorship extension
We are thrilled to announce that the Swiss National Science Foundation has granted us the full extension to our ongoing SNF Professorship! We are extremely thankful to the SNSF for this continued support.
SNF Professorships are among the most prestigious SNF funding for young principle investigators. The project continues to systematically analyze the molecular and cellular systems that determine why people can respond differently to medications.
ETH Zurich Research Grant
We’re thrilled to announce that the ETH Zurich has awarded us with an ETH Zurich Research Grant! ETH Grants are a competitive ETH-internal funding programme to promote world-​class research with the potential to result in fundamental new knowledge or technologies and exciting discoveries.
The grant will allow us to investigate the differences in behaviour and morphology of human inducible pluripotent stem cells (iPSCs) observed in different iPSC lines derived from the same human donor, as well as differences observed between iPSCs from different donors. The project builds on unique expertise by postdoc Sohyon Lee in the lab.
SNF Sinergia Grant
We are thrilled to announce that the Snijder Lab has been awarded an SNF Sinergia grant, together with the labs of Prof. Dr. Inti Zlobec at the University of Bern, Dr. Maria Anisimova at the Zurich University of Applied Sciences, and Dr. MarĂa RodrĂguez MartĂnez at IBM Research. Collectively we will work to advance our understanding of colorectal cancer.
EMBO Fellowship for Daniel
Daniel Greenwood has been awarded an EMBO Long Term Fellowship to study the influence of the gut microbiome on the human immune system! We are very greatful for EMBO’s support. Congrats Daniel!
Tumor Profiler preprint out
The Tumor Profiler consortium, a large public/private consortium of which the Snijder lab is proudly part, just published a preprint outlining the goals and setup of our ambitious study!